McNeil gains OTC status for Rhinocort in US

2 April 2015 - Deborah Wilkes


McNeil Consumer Healthcare is set to launch AstraZeneca's Rhinocort (budesonide) nasal spray as an OTC medicine in the US.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: